While consumers debate 'cotton-soft' versus 'mesh' sanitary pads, industry rules are quietly shifting. In August 2026, the group standard T/CIAA 008-2026 for antimicrobial sanitary pads, pantyliners, and period pants was officially released, replacing the 2020 version. This is not just a numerical adjustment of technical indicators but a precise industry correction of the ambiguous concept of 'antibacterial', with impacts rippling from testing labs to retail shelves.
Standard Revision: Stricter Definitions and Requirements
The most significant change is renaming 'bacteriostatic sanitary pads' to 'antimicrobial sanitary pads, pantyliners, and period pants', formally including 'period pants' in the title, reflecting the explosive growth of period panties. More notably, the new standard introduces a 'long-lasting antimicrobial' definition, requiring products to maintain antimicrobial activity after simulated use (applying bovine serum albumin to the skin-contact layer and storing at 36±1°C for at least 8 hours). This shifts the testing logic from 'can inhibit bacteria at factory' to 'still effective after use', challenging formulations in terms of sweat resistance, moisture resistance, and friction resistance.
Simultaneously, the new standard fully aligns with GB 15979-2024 for disposable sanitary products, adjusting requirements for antibacterial performance, bacteriostatic performance, stability, and toxicology, and adding corresponding long-lasting test methods. This embeds the national standard's latest baseline into the group standard, making T/CIAA 008-2026 one of the most comprehensive voluntary standards for sanitary pad antimicrobials in China. For purchasers, the revision means existing test reports may become invalid, and supply chain compliance reviews must accelerate.
Industry Transmission: Chain Reactions from Lab to Production Line
The direct beneficiaries are technologically prepared leading companies. Drafting units like Henan Shulai, Guangdong Institute of Microbiology, SGS, and Jinda Nano Technology have already positioned themselves in testing services and antimicrobial agent supply. For small and medium brands, the new long-lasting test implies higher testing costs and longer formulation adjustment cycles; those lacking R&D capabilities may face elimination.
For upstream antimicrobial agent suppliers, this is a structural opportunity. The introduction of BSA simulation tests will eliminate short-acting antimicrobial solutions relying on surface spraying, favoring slow-release agents like silver and zinc. For downstream brands, especially white-label products on e-commerce, the revision may trigger a 'compliance reshuffle'—products marketed as 'antibacterial' but lacking new standard test reports risk delisting or counterfeiting complaints.
From the terminal market perspective, the inclusion of period pants deserves attention. Period pants have grown rapidly due to comfort and leak prevention but lacked a unified antimicrobial evaluation system. The new standard fills this gap, expected to push period pants from 'concept marketing' to 'data endorsement', while providing clearer quality benchmarks for exporters and reducing trade frictions due to standard differences.
Practical Recommendations
For Purchasers - Immediately verify whether suppliers' test reports are based on T/CIAA 008-2026, requesting new long-lasting antimicrobial performance data. - Include 'standard revision' clauses in procurement contracts to define responsibilities for rework or returns due to standard updates. - Prioritize third-party institutions with CNAS/CMA qualifications and involvement in standard drafting to avoid invalid testing.
For Factories - Evaluate the slow-release performance of existing antimicrobial agents and collaborate with raw material suppliers to develop formulations meeting long-lasting requirements. - Upgrade temperature control in production lines to ensure product consistency under simulated use conditions (36±1°C). - Monitor supporting test methods under GB 15979-2024, and proactively procure or share test consumables like BSA to shorten testing cycles.
Every standard revision is a reordering of industry technical capabilities. The implementation of T/CIAA 008-2026 marks the transition of sanitary pad antimicrobials from the 'claim era' to the 'evidence era'. Rather than wait and see, companies should transform compliance costs into brand trust assets.